Uncategorized

The FDA has four big events in the coming two weeks, including an advisory panel meeting for an ultra-rare disease.

Fatalities are an unfortunate reality of clinical trials. How can companies best protect themselves?

After more than a decade devoid of therapeutic advancements, a first-in-class T cell receptor therapy could be on the immediate horizon for synovial sarcoma patients.

En diálogo exclusivo con IntraMed, el Dr. Alejandro Molina – Presidente de la Asociación Psiquiátrica Mexicana- nos describe los principales temas de la especialidad

 “I’m just kind of in shock,” an analyst said on the earnings call, asking for more detail on the forecast cut.

A spokesperson for Abbott said the recall “may impact less than 1% of Libre 3 users in the U.S.”

The European Medicines Agency’s Committee for Medicinal Products for Human Use found that Leqembi’s benefits do not outweigh the risks of severe side effects associated with the treatment.

Encouraged by the potential of the weight-loss candidates acquired from Carmot Therapeutics, Roche will speed up the development of its obesity programs, seeking to differentiate itself in the market.

Bristol Myers Squibb on Friday reported strong second-quarter results, led by the blood thinner Eliquis and cancer therapy Opdivo, as it looks to cut $1.5 billion in costs by 2025.

  La era de la inteligencia artificial (IA) ha llegado al marketing digital, transformando por completo la manera en que las empresas interactúan con sus audiencias. En este artículo, vamos a presentarte cómo la IA está revolucionando el marketing digital en Espa& …